What do systematic reviews say?

Intervention not reported

The intervention showed no clear difference in overall survival (at 36 months) (moderate certainty).

• Polyclonal anti‐thymocyte globulins for the prophylaxis of graft‐versus‐host disease after allogeneic stem cell or… 2023 · Cochrane Headline outcomes only
  HR 0.93 [0.77, 1.13]
  9 studies · 1249 participants
  Moderate